Elevation of urine trypsinogen 2 is an independent risk factor for pancreatic fistula after pancreaticoduodenectomy

Pancreas

Volumn 41, Issue 6, 2012, Pages 876-881

  Uemura, Kenichiro ^a   Murakami, Yoshiaki ^a   Sudo, Takeshi ^a   Hashimoto, Yasushi ^a   Nakashima, Akira ^a   Yamaoka, Emi ^a   Sueda, Taijiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

duct to mucosa pancreaticogastrostomy; International Study Group on Pancreatic Fistula; pancreaticoduodenectomy; postoperative pancreatic fistula; postoperative pancreatitis; urine trypsinogen 2

Indexed keywords

C REACTIVE PROTEIN; TRYPSINOGEN; TRYPSINOGEN 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; HYPERAMYLASEMIA; LEUKOCYTE COUNT; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PANCREAS FISTULA; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RISK FACTOR; STOMACH ANTRUM RESECTION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PANCREATIC FISTULA; PANCREATICODUODENECTOMY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TRYPSIN; TRYPSINOGEN; UP-REGULATION; YOUNG ADULT;

EID: 84863990134     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31823d0b82     Document Type: Article

References (20)

1. Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8Y13.
2. Wada K, Traverso LW. Pancreatic anastomotic leak after the Whipple procedure is reduced using the surgical microscope. Surgery. 2006;139:735Y742.
3. Kajiwara T, Sakamoto Y, Morofuji N, et al. An analysis of risk factors for pancreatic fistula after pancreaticoduodenectomy: clinical impact of bile juice infection on day 1. Langenbecks Arch Surg. 2010;395:707Y712.
4. Poon RT, Fan ST, Lo CM, et al. External drainage of pancreatic duct with a stent to reduce leakage rate of pancreaticojejunostomy after pancreaticoduodenectomy: a prospective randomized trial. Ann Surg. 2007;246:425Y433; discussion 433Y425.
5. Pratt WB, Callery MP, Vollmer CM Jr. Risk prediction for development of pancreatic fistula using the ISGPF classification scheme. World J Surg. 2008;32:419Y428.
6. Fuks D, Piessen G, Huet E, et al. Life-threatening postoperative pancreatic fistula (grade C) after pancreaticoduodenectomy: incidence, prognosis, and risk factors. Am J Surg. 2009;197:702Y709.
7. Murakami Y, Uemura K, Hayasidani Y, et al. A soft pancreatic remnant is associated with increased drain fluid pancreatic amylase and serum CRP levels following pancreatoduodenectomy. J Gastrointest Surg. 2008;12:51Y56.
8. Hedstrom J, Korvuo A, Kenkimaki P, et al. Urinary trypsinogen-2 test strip for acute pancreatitis. Lancet. 1996;347:729Y730.
9. Hashimoto Y, Traverso LW. Incidence of pancreatic anastomotic failure and delayed gastric emptying after pancreatoduodenectomy in 507 consecutive patients: use of a Web-based calculator to improve homogeneity of definition. Surgery. 2010;147: 503Y515.
10. Murakami Y, Uemura K, Hayashidani Y, et al. No mortality after 150 consecutive pancreatoduodenctomies with duct-to-mucosa pancreaticogastrostomy. J Surg Oncol. 2008;97:205Y209.
11. Winter JM, Cameron JL, Yeo CJ, et al. Biochemical markers predict morbidity and mortality after pancreaticoduodenectomy. J Am Coll Surg. 2007;204:1029Y1036; discussion 1037Y1028.
12. Itkonen O, Koivunen E, Hurme M, et al. Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis. J Lab Clin Med. 1990;115:712Y718.
13. Hedstrom J, Sainio V, Kemppainen E, et al. Serum complex of trypsin 2 and alpha 1 antitrypsin as diagnostic and prognostic marker of acute pancreatitis: clinical study in consecutive patients. BMJ. 1996;313:333Y337.
14. Ohlsson K, Eddeland A. Release of proteolytic enzymes in bile-induced pancreatitis in dogs. Gastroenterology. 1975;69:668Y675.
15. Kemppainen EA, Hedstrom JI, Puolakkainen PA, et al. Rapid measurement of urinary trypsinogen-2 as a screening test for acute pancreatitis. N Engl J Med. 1997;336:1788Y1793.
16. Neoptolemos JP, Kemppainen EA, Mayer JM, et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet. 2000;355:1955Y1960.
17. Raty S, Sand J, Nordback I. Detection of postoperative pancreatitis after pancreatic surgery by urine trypsinogen strip test. Br J Surg. 2007;94:64Y69.
18. Lai EC, Lau SH, Lau WY. Measures to prevent pancreatic fistula after pancreatoduodenectomy: a comprehensive review. Arch Surg. 2009;144:1074Y1080.
19. Vanounou T, Pratt WB, Callery MP, et al. Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands. J Am Coll Surg. 2007;205:546Y557.
20. Kollmar O, Moussavian MR, Bolli M, et al. Pancreatojejunal leakage after pancreas head resection: anatomic and surgeon-related factors. J Gastrointest Surg. 2007;11:1699Y1703.